Growth Metrics

Travere Therapeutics (TVTX) Operating Income Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 12.69%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 75.16%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -347.04%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 80.62%
7 Evaxion A 64.16 Bn 64.14 Bn - 1.27%
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 8.65%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 1,386.07%
10 Travere Therapeutics 4.34 Bn 4.26 Bn 102.38 Mn 13.50%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 13.50%
Dec 31, 2025 46.61%
Sep 30, 2025 144.40%
Jun 30, 2025 81.32%
Mar 31, 2025 69.35%
Dec 31, 2024 35.55%
Sep 30, 2024 39.35%
Jun 30, 2024 34.87%
Mar 31, 2024 -43.00%
Dec 31, 2023 -8.69%
Sep 30, 2023 -12.08%
Jun 30, 2023 -32.38%
Mar 31, 2023 -35.27%
Dec 31, 2022 -2.18%
Sep 30, 2022 -160.49%
Jun 30, 2022 -122.36%
Mar 31, 2022 -51.38%
Dec 31, 2021 28.43%
Sep 30, 2021 -63.16%
Jun 30, 2021 -52.81%
Mar 31, 2021 -215.58%
Dec 31, 2020 -320.88%
Sep 30, 2020 43.56%
Jun 30, 2020 36.73%
Mar 31, 2020 60.59%
Dec 31, 2019 -465.04%
Sep 30, 2019 3.22%
Jun 30, 2019 -69.43%
Mar 31, 2019 -113.42%
Dec 31, 2018 67.15%
Sep 30, 2018 -235.44%
Jun 30, 2018 -58.55%
Mar 31, 2018 -24.32%
Dec 31, 2017 16.71%
Sep 30, 2017 47.93%
Jun 30, 2017 -19.50%
Mar 31, 2017 -74.83%
Dec 31, 2016 -19.85%
Sep 30, 2016 0.60%
Jun 30, 2016 -63.87%
Mar 31, 2016 -1.69%
Dec 31, 2015 18.68%
Sep 30, 2015 6.27%
Jun 30, 2015 59.59%
Mar 31, 2015 63.27%
Dec 31, 2014 -60.60%
Sep 30, 2014 -262.59%
Jun 30, 2014 -307.64%
Mar 31, 2014 -880.53%